PEBP1 and cancer: Using the gene expression profiling interactive analysis (GEPIA) [117], which derives molecular data from the Cancer Genome Atlas Program (TCGA), we found a significant negative regulation (p < 0.05) between RKIP and PD-L1 in 8 out of 34 cancer types provided, namely BLCA, BRCA, COAD, HNSC, cervical squamous cell carcinoma (CESC), esophageal carcinoma (ESCA), LUAD, and thyroid carcinoma (THCA) (Figure 4A).